Operating income increased 14.6%
Operating income changed +14.6% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income changed +14.6% from the comparable as-filed period.
Stock-based compensation changed -34.5% from the comparable as-filed period.
Net debt changed -26.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Capital expenditure changed -39.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Gross margin changed +136 basis points from the comparable as-filed period.
Current assets changed -19.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Cash / debt changed +2028 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Free-cash-flow margin changed +1754 basis points from the comparable as-filed period.
Operating cash-flow margin changed +1656 basis points from the comparable as-filed period.
Gross profit changed +22.6% from the comparable as-filed period.
Receivables / revenue changed -558 basis points from the comparable as-filed period.
Net income changed +11.2% from the comparable as-filed period.
Debt / revenue changed -1821 basis points from the comparable as-filed period.
Capex / revenue changed -99 basis points from the comparable as-filed period.
Debt / assets changed +199 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Inventory changed -9.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Current ratio changed -23.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Cost of revenue changed +15.8% from the comparable as-filed period.
Current liabilities changed +6.1% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Shares outstanding changed +0.3% from the comparable as-filed period. The change ranks at the 12th percentile of 8 prior comparable changes.
R&D / revenue changed -110 basis points from the comparable as-filed period.
Research & development changed -4.6% from the comparable as-filed period.
Trade receivables changed +5.2% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Gross debt changed +1.4% from the comparable as-filed period. The change ranks at the 17th percentile of 6 prior comparable changes.
Reported total debt changed +1.4% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.